Spina Bifida
|
0.330 |
Biomarker
|
disease |
BEFREE |
Vangl2 disruption alters the biomechanics of late spinal neurulation leading to spina bifida in mouse embryos.
|
29590636 |
2018 |
Spina Bifida
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Overexpression of Grainyhead-like 3 causes spina bifida and interacts genetically with mutant alleles of Grhl2 and Vangl2 in mice.
|
30189017 |
2018 |
Spina Bifida
|
0.330 |
Biomarker
|
disease |
BEFREE |
Protein tyrosine kinase 7 (Ptk7) was shown to cause a very severe form of NTDs called craniorachischisis in a mouse model and genetically interacts with a core PCP member Vangl2 where double heterozygotes suffer from spina bifida.
|
26368655 |
2015 |
Spina Bifida
|
0.330 |
Biomarker
|
disease |
CTD_human |
A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene.
|
21404367 |
2011 |
Status Dysraphicus
|
0.300 |
Biomarker
|
disease |
CTD_human |
A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene.
|
21404367 |
2011 |
Rachischisis
|
0.300 |
Biomarker
|
disease |
CTD_human |
A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene.
|
21404367 |
2011 |
Spina bifida aperta of cervical spine
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Contribution of VANGL2 mutations to isolated neural tube defects.
|
20738329 |
2011 |
Diastematomyelia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Neurenteric Cyst
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Tethered Cord Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Iniencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Exencephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Spinal Cord Myelodysplasia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Acrania
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cranial effects of retinoic acid in the loop-tail (Lp) mutant mouse.
|
2373757 |
1990 |
Neural tube defects X-linked
|
0.200 |
Biomarker
|
disease |
MGD |
Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects.
|
9545534 |
1998 |
Spina Bifida, X-Linked
|
0.200 |
Biomarker
|
disease |
MGD |
Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects.
|
9545534 |
1998 |
Neural tube defect, folate-sensitive
|
0.200 |
Biomarker
|
disease |
MGD |
Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects.
|
9545534 |
1998 |
Spina Bifida, Folate-Sensitive
|
0.200 |
Biomarker
|
disease |
MGD |
Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects.
|
9545534 |
1998 |
Meningomyelocele
|
0.110 |
Biomarker
|
disease |
BEFREE |
PCP rare putative mutations had a weaker role in myelomeningocele (SB), being found in approximately 6% of cases and cumulated across CELSR1, FUZ, FZD6, PRICKLE1, VANGL1, and VANGL2.
|
23024041 |
2012 |
Meningomyelocele
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Addison Disease
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hydrocephalus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lipoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Urinary Incontinence
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|